Tuesday, November 19, 2019 Daily Archives

Closed, Single-Use TFF Assembly Makes Performance-Leading TangenX Cassette Technologies Even Easier to Use

This webcast features: Michael LaBreck, Global Bioprocess Sales Specialist, TangenX™ TFF Products, Repligen Corporation SIUS-Gamma TFF cassettes incorporate the performance-leading TangenX™ TFF membrane and cassette manufacturing technologies into a closed, gamma-irradiated, single-use assembly. Genderless, aseptic connections easily integrate into your current UF/DF flow path, and a library of 64 MWCO and surface area configurations provide rich process options. The closed format, leading TFF performance (flux, selectivity, reproducibility) of the TangenX membrane and manufacturing innovations that enabled the first single-use by…

Asahi Kasei Bioprocess’ Planova SU-VFC: Realizing Single-Use Technology in Virus Filtration

This webcast features: Brian Crawford, Director of Operations, Asahi Kasei Bioprocess America, Inc. By eliminating the need for clean-in-place, reducing demands on quality control, and optimizing product changeover times, single-use systems offer great benefit at pilot, clinical, and commercial production scales. The new Planova™ Single-Use Virus Filtration Controller (SU-VFC) from Asahi Kasei Bioprocess America, Inc. offers the hallmark consistency of Planova™ filters in a compact, fully automated single-use form factor with full 21 CFR Part 11 compliance for greater efficiency…

Viralgen $55m plant to bring commercial vector production to Spain

A GMP facility equipped with bioreactors of up to 2,000 L will be the first commercial gene therapy production site in Spain, says CDMO Viralgen. Contract development and manufacturing organization (CDMO) Viralgen will invest upwards of €50 million ($55 million) at its site at the Miramon Technology Park in San Sebastian, Spain to add capacity for gene therapy manufacturing services. “We have a cGMP facility up and running that will have three production rooms by Q1 2020,†CEO Javier García…